Korea’s Corestem, Kyongbo Plan IPOs On Bullish Sentiment
This article was originally published in PharmAsia News
Executive Summary
With global biotech and pharma stocks in the spotlight this year, more South Korean companies are trying to benefit from the bullish market sentiment and go public. Most recently, Corestem and Kyongbo Pharm have filed IPO plans to debut on stock markets in June.